Objective To explore whether sivelestat sodium could reduce the expression of mucin 5AC(MUC5AC)in intrahepatic bile duct epithelial cells by inhibiting neutrophil elastase(NE)and thus provide new potential therapeutic ideas for the treatment of intrahepatic bile duct stone(IBDS).Methods ①Bioinformatics analysis:differential gene analysis was performed on gallbladder stone cholecystitis sequencing data based on the gene expression omnibus(GEO)to screen for significantly different genes related to neutrophils and mucins.The search tool for the retrieval of interacting genes database(STRING)was used for protein interaction analysis to predict whether there was an interaction between NE and MUC5AC genes.②Animal experiment:a total of 18 male SD rats were divided into the sham-operated group,cholangitis model group and sivelestat sodium treatment group according to the random number table method,with 6 rats in each group.The cholangitis rat model was established by a one-time injection of 1.25 mg/kg lipopolysaccharide(LPS)into the right anterior lobe of the liver of rats in combination with the pre-experiment;the liver of the sham-operated group was injected with an equal volume of saline.After the modelling,100 mg/kg of sivelestat sodium was injected into the tail vein of the cevalexin treatment group once a day for 5 days,and an equal volume of saline was injected into the tail vein of the sham-operated group and the cholangitis model group.Two weeks later,the rats were euthanized and their liver and bile duct tissues were taken.The pathological changes in the liver and bile duct tissues were observed under the light microscope.Immunohistochemical staining was used to detect the expressions of NE and MUC5AC in liver and bile duct tissues.The protein expressions of NE,MUC5AC and Toll-like receptor 4(TLR4)were detected by Western blotting.③Cell experiment:primary human intrahepatic biliary epithelial cell line(HiBEpiC)was divided into blank control group,NE group(10 nmol/L NE),NE+sivelestat sodium low dose group(10 nmol/L NE+1×10-8 g/L sivelestat sodium 1 mL),NE+sivelestat sodium medium dose group(10 nmol/L NE+1×10-7 g/L sivelestat sodium 1 mL),NE+sivelestat sodium high dose group(10 nmol/L NE+1×10-6 g/L sivelestat sodium 1 mL).Cells were collected after 48 hours of culture,and EdU was performed to detect the proliferative activity of cells;enzyme linked immunosorbent assay(ELISA)and Western blotting were performed to detect the expression of MUC5AC in cells.Results ①Bioinformatics analysis:the NE gene(ELANE)had a reciprocal relationship with MUC5AC.②Animal experiment:light microscopy showed that hepatocyte edema,hepatocyte diffuse point and focal necrosis,confluent area fibrous tissue and intrahepatic bile ducts hyperplasia and inflammatory cell infiltration in the cholangitis model group;hepatic lobule structure of sivelestat sodium treatment group was clear,and the degree of peripheral inflammatory cell infiltration was reduced compared with the cholangitis model group.Immunohistochemical staining showed that the expressions of NE and MUC5AC were increased in the cholangitis model group compared with the sham-operated group,and the expressions of NE and MUC5AC were decreased in the sivelestat sodium group compared with the cholangitis model group[NE(A value):5.23±2.02 vs.116.67±23.06,MUC5AC(A value):5.40±3.09 vs.23.81±7.09,both P<0.05].Western blotting showed that the protein expressions of NE,MUC5AC,and TLR4 in the hepatic biliary tissues of the cholangitis model group were significantly higher than those of the sham-operated group;and the protein expressions of NE,MUC5AC,and TLR4 in the liver biliary tissues of the sivelestat sodium treatment group were significantly higher than those of the sham-operated group(NE/β-actin:0.38±0.04 vs.0.70±0.10,MUC5AC/β-actin:0.37±0.03 vs.0.61±0.05,TLR4/β-actin:0.39±0.10 vs.0.93±0.15,all P<0.05).③Cell experiment:fluorescence microscopy showed that the proliferation of HiBEpiC cells in each group was good,and there was no significant difference in the proportion of positive cells.ELISA and Western blotting showed that the expressions of MUC5AC in cells of the NE group were significantly higher than those of the blank control group.The expressions of MUC5AC in the NE+different dose of sivelestat sodium group were significantly lower than those in the NE group,and showed a decreasing trend with the increase of sevastatin sodium concentration,especially in the highest dose group[MUC5AC(μg/L):3.46±0.20 vs.6.33±0.52,MUC5AC/β-actin:0.45±0.07 vs.1.75±0.10,both P<0.05].Conclusion LPS can upregulate the expression of NE and MUC5AC in rats with cholangitis,while sodium sivelestat can reduce the expression of MUC5AC in in intrahepatic biliary epithelial cells by inhibiting NE,providing a new direction for the treatment of IBDS.
Sivelestat sodiumNeutrophil elastaseMucin 5ACIntrahepatic bile duct stone
NETL
NSTL
万方数据
